Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
guigui zhuanggu
- Development stage
- Unknown
- Lead developer
- Guang'anmen Hospital
- Administration
- Oral
01
Overview
Guigui Zhuanggu is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Xiangshan Hospital of Traditional Chinese Medicine in Shanghai. It is primarily indicated for the treatment of postmenopausal osteoporosis and associated low back pain. The formulation is based on TCM theories of tonifying the kidney and strengthening the skeleton (补肾壮骨). It is typically administered orally in tablet form. Clinical evaluation has focused on its efficacy in reducing pain and improving bone health when used as an adjuvant to standard calcium and vitamin D supplementation (Calci D).
- Brand names
- Guigui Zhuanggu Tablets
- Other names
- Guigui Zhuanggu Pian龟归壮骨片
Beyond the preview
Go deeper on guigui zhuanggu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on guigui zhuanggu.